Zenopa4d
Abbott’s Strategic Expansion in Diabetes Tech Offers Growth Opportunities
Abbott is making significant strides in the diabetes technology sector, with CEO Robert Ford highlighting the potential of continuous glucose monitors (CGMs) to reach a wider market. This growth is ...
Zenopa4d
Evolving Debate on Water Fluoridation’s Effectiveness
Experts reassess water fluoridation's effectiveness as fluoride toothpaste usage rises, affecting policies in regions like ...
Zenopa5d
bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines
BioAffinity Technologies’ (Nasdaq: BIAF) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the peer-reviewed paper, “Implementation of ...
Zenopa6d
Ovation Agriculture and SRUC Revolutionize Cattle Health with New Dental Gag
Ovation Agriculture, emerging from Scotland’s Rural College, is set to revolutionise cattle health with its new dental gag. This innovative tool, designed to facilitate thorough examination of cows’ ...
Zenopa6d
Imuldosa: New FDA-Approved Biosimilar for Inflammation
The FDA’s recent approval of Imuldosa, developed by Accord BioPharma as a biosimilar to Stelara, marks an expansion in treatments for chronic inflammatory conditions. This approval, encompassing ...
Zenopa6d
Refeyn introduces new mass photometry products to streamline biomolecular analysis workflows
Refeyn, the company behind pioneering mass photometry technologies, has taken another step to assure mass photometry is a simpler, more efficient bioanalytics tool with the release of a powerful ...
Zenopa7d
Lundbeck’s Acquisition of Longboard Could Revolutionize Neuro-Rare Treatment
Danish pharmaceutical company Lundbeck is making waves in the biopharma industry with its $2.6 billion acquisition of the biotechnology firm Longboard Pharmaceuticals. This strategic move targets the ...
Zenopa7d
Join industry experts at Dechra’s exclusive CPD sessions at LVS
Dechra is hosting an exclusive series of CPD sessions at the London Vet Show (LVS) on Thursday 14 and Friday 15 November featuring leading veterinary experts. The four CPD sessions cover an exciting ...
Zenopa8d
Abbott Expands Pulsed Field Ablation Research with FDA Clearance
Abbott, a global leader in healthcare innovation, has received FDA clearance for its advanced cardiac mapping technology. This clearance is a big step in its ongoing clinical studies of pulsed field ...
Zenopa8d
Medtronic Explores Dual-Energy Ablation for VT Treatment
Medtronic, a leading player in medical technology, is evaluating its Affera mapping and ablation system featuring the Sphere-9 catheter for treating ventricular tachycardia (VT). This heart rhythm ...
Zenopa10d
Roche’s New Breast Cancer Drug Itovebi: FDA Approval and Market Impact
Roche's Itovebi gains FDA approval for breast cancer, challenging Novartis and AstraZeneca with potential $2.3 billion sales.